The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries
Since 2011, GAVI, The Vaccine Alliance, has funded eligible countries to introduce rubella-containing vaccination (RCV) into their national schedule. Two key indicators used to monitor the impact – the future deaths and DALYs (Disability Adjusted Life Years) averted through vaccination conducted in...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis Group
2019-02-01
|
| Reeks: | Human Vaccines & Immunotherapeutics |
| Onderwerpen: | |
| Online toegang: | http://dx.doi.org/10.1080/21645515.2018.1532257 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|